Downstream Processing Featured Articles

61. FDA Approves First Drug-Eluting Stent To Treat Peripheral Arterial Disease 11/15/2012

    The U.S. Food and Drug Administration approved the Zilver PTX Drug-Eluting Peripheral Stent (Zilver PTX Stent), the first drug-eluting stent indicated to re-open a particular artery in the thigh (femoropopliteal artery) when narrowed or blocked as a result of peripheral artery disease (PAD).

62. New Monoclonal Antibody Developed That Can Target Proteins Inside Cancer Cells 3/13/2013

    Researchers have discovered a unique monoclonal antibody that can effectively reach inside a cancer cell, a key goal for these important anticancer agents, since most proteins that cause cancer or are associated with cancer are buried inside cancer cells.

63. Researchers Discover Blood Biomarker For Lou Gehrig's Disease, Could Lead To New Treatments 8/6/2012

    Researchers from Brigham and Women's Hospital (BWH) are the first to discover that changes in monocytes (a type of white blood cell) are a biomarker for amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease. 

64. COVID-19 Consortium: Competitive Collab On A Plasma-Derived Therapy 12/14/2020

    A host of global biopharma competitors are collaborating under the CoVIg-19 Plasma Alliance to secure enough convalescent plasma to produce an effective COVID-19 therapeutic at global scale. Takeda’s Dr. Thomas R. Kreil will present at the upcoming FDA/Xavier PharmaLink Conference.

65. Researchers' Sequencing Of Human and Monkey Malaria Genomes Reveals Challenges, Opportunities In Battle Against Parasite 8/5/2012

    Genetic variability revealed in malaria genomes newly sequenced by two multi-national research teams points to new challenges in efforts to eradicate the parasite, but also offers a clearer and more detailed picture of its genetic composition, providing an initial roadmap in the development of pharmaceuticals and vaccines to combat malaria.

66. 'Patch on a Chip' under development by Axon Instruments 11/1/2000
    New fabrication method will allow thousands of simultaneous patch clamp recordings...
67. TAP Collaborates With CCRM On Process Optimisation Project For Cell Therapies 12/3/2012

    TAP Biosystems, a leading supplier of innovative cell culture systems and consumables for life science applications, has joined the Centre for Commercialization of Regenerative Medicine’s (CCRM) industry consortium to translate laboratory cell culture conditions into optimized processes and media for commercial production of cellular therapies.

68. Breast Cancer Clinical Trial To Test Combination Of Heat Shock Protein Inhibitor And Hormonal Therapy 5/22/2012

    Pushed to the brink of survival, the hyper-driven cells of a cancerous tumor tap into an ancient system that has helped organisms cope with internal stresses and environmental challenges since life began. By Nicole Giese Rura

69. New Gene Mutations Linked To ALS And Nerve Cell Growth Dysfunction 7/16/2012

    Researchers have linked newly discovered gene mutations to some cases of the progressive fatal neurological disease amyotrophic lateral sclerosis - ALS, also known as Lou Gehrig's disease. 

70. GE Healthcare launches modular biopharmaceutical factory, KUBio 9/4/2012

    GE Healthcare, the healthcare business of GE, today introduced KUBio™, an innovative off-the-shelf, modular factory designed to save manufacturers of biopharmaceuticals both time and money.  KUBio’s pre-made modules, which are assembled at a customer’s chosen site to make a fully functional ready-to-run bioprocessing facility, are significantly faster to install than constructing a traditional factory.